Article info
Review
Intravitreal antivascular endothelial growth factor in diabetic macular oedema: scoping review of clinical practice guidelines recommendations
- Correspondence to Dr Manuel Vargas-Peirano, Interdisciplinary Center for Health Studies CIESAL, Facultad de Medicina, Universidad de Valparaiso, Vina del Mar, Chile; manuel.vargas{at}uv.cl
Citation
Intravitreal antivascular endothelial growth factor in diabetic macular oedema: scoping review of clinical practice guidelines recommendations
Publication history
- Received April 20, 2021
- Accepted November 23, 2021
- First published December 14, 2021.
Online issue publication
February 20, 2023
Article Versions
- Previous version (14 December 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.